Nephrology and Urology Devices Market Research and Forecast Report 2024-2032


MARKETRESEARCH

Uploaded on May 3, 2024

Category Business

According to the latest research report by IMARC Group, The global nephrology and urology devices market size reached US$ 6.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 10.9 Billion by 2032, exhibiting a growth rate (CAGR) of 5.4% during 2024-2032. More Info:- https://www.imarcgroup.com/nephrology-urology-devices-market

Category Business

Comments

                     

Nephrology and Urology Devices Market Research and Forecast Report 2024-2032

Global Nephrology and Urology Devices Market Research and Forecast Report 2024-2032 Format: PDF+EXCEL © 2023 IMARC All Rights Reserved About IMARC Group In ternat ional Market Analys is Research and Consul t ing Group is a leading adv iser on management s t rategy and market research wor ldwide. We par tner wi th c l ients in a l l regions and indust ry vert ica ls to ident i fy thei r h ighest -value oppor tuni t ies, address thei r most cr i t ica l chal lenges, and t ransform thei r bus inesses. IMARC’s in format ion products inc lude major market , sc ient i f ic , economic and technological developments for bus iness leaders in pharmaceut ica l , indust r ia l , and h igh technology organizat ions. Market forecasts and indust ry analys is for b iotechnology, advanced mater ia ls , chemicals , food and beverage, t ravel and tour ism, nanotechnology and novel process ing methods are at the top of the company’s exper t ise. IMARC’s ta i lored approach combines unfathomable ins ight in to the dynamics o f companies and markets wi th c lose cooperat ion at a l l levels of the c l ient organizat ion. This ensures that our c l ients achieve unmatchable compet i t ive advantage, bui ld more pro f ic ient organizat ions, and secure las t ing resul ts . A c c o r d i n g t o t h e l a t e s t r e p o r t b y I M A R C G r o u p , t i t l e d " N e p h r o l o g y a n d U r o l o g y D e v i c e s M a r k e t : G l o b a l I n d u s t r y T r e n d s , S h a r e , S i z e , G r o w t h , O p p o r t u n i t y a n d F o r e c a s t 2 0 2 4 - 2 0 3 2 , " t h e g l o b a l n e p h r o l o g y a n d u r o l o g y d e v i c e s m a r k e t s i z e r e a c h e d U S $ 6 .7 B i l l i o n i n 2 0 2 3 . F a c to rs A f fe c t in g th e G ro w th o f th e N e p h ro lo g y a n d U ro lo g y D e v ic e s In d u s t ry : Report T e c h n o lo g ic a l A d v a n c em e n ts : T h e e v o l u t i o n o f m e d i c a l t e c h n o l o g y h a s r e v o l u t i o n i z e d n e p h r o l o g y a n d u r o l o g y d e v i c e s , d r i v i n g t h e m a r k e t f o r w a r d . I n n o v a t i o n s l i k e a d v a n c e d i m a g i n g t e c h n i q u e s , r o b o t i c - Highlight and a s s i s t e d s u r g e r i e s , a n d i m p l a n t a b l e d e v i c e s h a v e t r a n s f o r m e d d i a g n o s i s , t r e a t m e n t , a n d m a n a g e m e n t o f k i d n e y a n d u r i n a r y t r a c t d i s o r d e r s . F o r i n s ta n c e , r o b o t i c - a s s i s t e d s u r g e r i e s o f f e r g r e a t e r p r e c i s i o n a n d d e x te r i t y , l e a d i n g t o b e t t e r s u r g i c a l o u t c o m e s a n d Description s h o r t e r r e c o v e r y t i m e s . A d d i t i o n a l l y , a d v a n c e m e n t s i n i m a g i n g t e c h n o l o g y e n a b l e m o r e a c c u r a t e d i a g n o s i s o f u r o l o g i c a l c o n d i t i o n s , f a c i l i t a t i n g t a r g e te d t r e a t m e n t p l a n s . T h e s e t e c h n o l o g i c a l a d v a n c e m e n ts i m p r o v e p a t i e n t c a r e a n d e n h a n c e h e a l t h c a r e p r o v i d e r e f f i c i e n c y a n d s a t i s f a c t i o n . A s r e s e a r c h a n d d e v e l o p m e n t c o n t i n u e t o p u s h t h e b o u n d a r i e s o f i n n o v a t i o n , t h e n e p h r o l o g y a n d u r o l o g y d e v i c e s m a r k e t i s p o i s e d f o r f u r t h e r g r o w t h a n d e v o l u t i o n . Increas ing Preva lence o f Chron ic K idney D iseases ( CKD) and Uro log ica l D isorders : T he r i s i n g i n c i d e nc e o f c h r on i c k i dn e y d i s e a s e s ( C K D ) a n d u r o l og i c a l d i so r d e rs g l o ba l l y u n de r s c o re s t h e c r i t i c a l i m po r t a n ce o f n e ph r o l o g y a nd u r o l o gy d e v i ce s i n he a l t h c a re . F ac t o r s s u ch a s a g i ng p op u l a t i o ns , se d e n ta r y l i f e s t y l e s , a nd th e i n c r e a s i n g Report p r e v a l e n ce o f c o n d i t i o n s l i k e d i a b e t e s a n d h y p e r t e n s i o n c o n t r i b u t e t o t h e g r o w i ng bu r d e n o f t h e s e d i s e a se s . C o n se q u e n t l y , t h e re i s a h e i gh t e n ed d e ma n d f o r d i ag n o s t i c Highlight and t oo l s , t r e a t me n t mo d a l i t i e s , a n d m a n ag e m en t d ev i c e s i n ne p h ro l o g y an d u r o l o g y . F ro m d i a g n os t i c i m a g i ng e qu i p m en t t o re n a l r e p l a ce m e n t t he r a p y d e v i c e s , t he m a r k e t en c o m pa s s e s a w i d e a r r a y o f p r o d u c t s a i m e d a t a d d r es s i n g t h e d i v e r se n e ed s o f Description pa t i e n t s w i t h k i d n ey a nd u ro l o g i c a l c o n d i t i o n s . T h i s t r e nd i s ex p e c t e d to c o n t i n u e d r i v i n g t he g r ow t h o f t h e n e p h r o l o g y a nd u r o l og y d ev i c e s m a rk e t a s h ea l t h c a r e sy s t e ms s t r i v e to m e e t t h e e s c a l a t i n g d e ma n d f o r e f f e c t i v e t r e a t m e n t s . Growing Demand f or Min imal ly Invas ive Procedures : T he r i s i n g p r e fe r e nc e f o r m i n i ma l l y i n v a s i v e p r o ce d u r e s i n n e p h r o l o g y a n d u r o l o g y i s f ue l e d b y th e d e s i r e f o r i mp r o v ed p a t i e n t o u t c om e s an d re d u c e d h e a l t hc a r e c o s t s . M i n i m a l l y i n v a s i v e te c h n i q ue s o f f e r n u m er o u s a d v a n ta g e s o v e r t r a d i t i o n a l o p en su r g e r i es , i n c l u d i n g s h o r te r h o sp i t a l s ta y s , f a s t e r re c o v e r y t i m es , a n d de c r e as e d r i s k o f c o mp l i c a t i o ns . Th is sh i f t in su rg ica l approach has led to a co r respond ing inc rease in demand fo r assoc ia ted dev ices such as u re te roscopes , l i t ho t r i p te rs , and s ten ts . These dev ices enab le hea l thca re p rov ide rs to pe r fo rm comp lex p rocedu res w i th g rea te r p rec is ion and min ima l t i ssue t rauma, resu l t ing in be t te r pa t ien t exper iences and ou tcomes. As pa t ien t awareness and accep tance o f min ima l ly invas ive techn iques g row, the re i s a he igh tened demand fo r i nnova t ive Report neph ro logy and u ro logy dev ices des igned to suppor t these p rocedures , t hus fue l ing marke t g rowth . Highlight and Request for a PDF sample o f th is repor t : h t tps : / /www. imarcgroup .com/nephro logy-u ro logy-dev ices-marke t / reques tsamp le Description Report Description Global Nephrology and Urology Devices Market Trends: The w idesp r ead adop t i on o f cus t om er - ce n t r i c co r e s t r a t eg ie s , a lo ng w i t h t h e r i s in g ne ed t o im p r ove p r odu c t i v i t y an d ope r a t i ona l e f f i c i enc y i n t he ban k ing sec t o r i s m a jo r l y d r i v i ng t h e t h i r d - pa r t y ba nk ing so f t wa r e m ar k e t g r o w t h . Add i t io na l l y , t he i nc r e as ing u t i l i z a t i on o f d ig i t a l p aym en t so lu t i on s and t h e i nco r po r a t i on o f b ig da t a ana l y t i c s i n t o t h i r d - pa r t y b ank in g so f t wa r e t o p r oce ss l a r ge a m ou n t s o f da t a f o r m ak ing a ccu r a t e bus in ess d ec i s ion s a nd id en t i f y m ar ke t t r end s a r e ca t a l yz in g t h e m a r ke t g r ow t h . I n l i ne w i t h t h i s , t he su r g ing p a r t n e r sh i ps be t ween r egu la t e d f i na nc ia l i ns t i t u t i ons and a l t e r na t i ve f i na nc ia l co m pa n ies a r e ac t i ng as ano t he r g r ow t h - i ndu c ing f a c t o r . Due t o t he p r o l i f e r a t i on o f sm a r t pho nes , consu m er s a r e i nc r eas i ng s h i f t i ng t owar d com pu t e r i zed acco un t i ng f o r book keep ing and m o ne t a r y t r an sac t i ons . T h i s , i n t u r n , i s f ac i l i t a t i ng t he dem and f o r soph is t i ca t ed , r i s k - f r ee , com p l i an t , an d da t a - d r iv en so f t wa r e , l i ke t h i r d - pa r t y bank ing so f t wa r e , wh i ch i s c r ea t i ng a pos i t i ve o u t l ook f o r t he m ar k e t . Look i ng f o rw ard , I M A RC G rou p ex pec t s t he ma rke t t o reach US$ 10 . 9 B i l l i on by 2032 , exh i b i t i ng a g row t h ra t e ( CAG R) o f 5 . 4% d ur i n g 2024 - 203 2 . V i ew Repo r t T O C, F i g ures and T ab l e s : h t t ps : / / w w w . i mar cgrou p . com / ne phro l ogy - uro l o gy - d ev i ce s - m arke t Breakup by Product: • Ureteral Catheters • PCN Catheters • Urinary Stents • Stone Basket • Urology Guidewires Report • Renal Di lators Segmentation • Others Breakup by End Use: • Hospitals and Cl inics • Ambulatory Surgery Centers • Others Breakup by Region: • North America • Europe • Asia-Pacifi c • Latin America Report • Middle East and Afr ica Segmentation • Asahi Kasei Corporat ion • B. Braun Melsungen AG • Baxter International Inc. • Becton Dickinson and Company Competitive • Boston Scient ifi c Corp. Landscape • Coloplast A/S • Cook Group Inc. with Key • Fresenius Medical Care AG & Co. KGaA Players • Medtronic plc • Nipro Corporat ion • Nxstage Medical Inc. (Fresenius Medical Care) How has the global nephrology and urology devices market performed so far, and how will it perform in the coming years? What are the drivers, restraints, and opportunities in the global nephrology and urology devices market? What is the impact of each driver, restraint, and Key opportunity on the global nephrology and urology devices market? Questions What are the key regional markets? Answered in the Report Which countries represent the most attractive nephrology and urology devices market? What is the breakup of the market based on the product? Which is the most attractive product in the nephrology and urology devices market? What is the breakup of the market based on the end use? Which is the most attractive end use in the nephrology and urology devices market? Key Questions What is the competitive structure of the market? Answered in Who are the key players/companies in the global nephrology and urology devices market? the Report 1 P r e f a c e 2 S c o p e a n d M e t h o d o l o g y 2 . 1 O b j e c t i v e s o f t h e S t u d y 2 . 2 S t a k e h o l d e r s 2 . 3 D a t a S o u r c e s 2 . 3 . 1 P r i m a r y S o u r c e s 2 . 3 . 2 S e c o n d a r y S o u r c e s 2 . 4 M a r k e t E s t i m a t i o n Table of 2 . 4 . 1 B o t t o m - U p A p p r o a c h 2 . 4 . 2 T o p - D o w n A p p r o a c h 2 . 5 F o r e c a s t i n g M e t h o d o l o g y 3 E x e c u t i v e S u m m a r y 4 I n t r o d u c t i o n Contents 4 . 1 O v e r v i e w 4 . 2 K e y I n d u s t r y T r e n d s5 G l o b a l N e p h r o l o g y a n d U r o l o g y D e v i c e s M a r k e t 5 . 1 M a r k e t O v e r v i e w 5 . 2 M a r k e t P e r f o r m a n c e 5 . 3 I m p a c t o f C O V I D - 1 9 5 . 4 M a r k e t F o r e c a s t 6 M a r k e t B r e a k u p b y P r o d u c t 6 . 1 U r e t e r a l C a t h e t e r s 6 . 1 . 1 M a r k e t T r e n d s 6 . 1 . 2 M a r k e t F o r e c a s t 6 . 2 P C N C a t h e t e r s 6 . 2 . 1 M a r k e t T r e n d s 6 . 2 . 2 M a r k e t F o r e c a s t 6 . 3 U r i n a r y S t e n t s 6 . 3 . 1 M a r k e t T r e n d s 6 . 3 . 2 M a r k e t F o r e c a s t 6 . 4 S t o n e B a s k e t 6 . 4 . 1 M a r k e t T r e n d s 6 . 4 . 2 M a r k e t F o r e c a s t 6 . 5 U r o l o g y G u i d e w i r e s 6 . 5 . 1 M a r k e t T r e n d s 6 . 5 . 2 M a r k e t F o r e c a s t 6 . 6 R e n a l D i l a t o r s 6 . 6 . 1 M a r k e t T r e n d s 6 . 6 . 2 M a r k e t F o r e c a s t 6 . 7 O t h e r s 6 . 7 . 1 M a r k e t T r e n d s 6 . 7 . 2 M a r k e t F o r e c a s t Table of 7 M a r k e t B r e a k u p b y E n d U s e 7 . 1 H o s p i t a l s a n d C l i n i c s 7 . 1 . 1 M a r k e t T r e n d s Contents 7 . 1 . 2 M a r k e t F o r e c a s t 7 . 2 A m b u l a t o r y S u r g e r y C e n t e r s 7 . 2 . 1 M a r k e t T r e n d s 7 . 2 . 2 M a r k e t F o r e c a s t 7 . 3 O t h e r s 7 . 3 . 1 M a r k e t T r e n d s 7 . 3 . 2 M a r k e t F o r e c a s t 8 M a r k e t B r e a k u p b y R e g i o n 8 . 1 N o r t h A m e r i c a 8 . 1 . 1 U n i t e d S t a t e s 8 . 1 . 1 . 1 M a r k e t T r e n d s 8 . 1 . 1 . 2 M a r k e t F o r e c a s t 8 . 1 . 2 C a n a d a 8 . 1 . 2 . 1 M a r k e t T r e n d s 8 . 1 . 2 . 2 M a r k e t F o r e c a s t F o r m o r e i n f o r m a t i o n , v i s i t : h t t p s : / / w w w. im a rcg ro u p . co m / n ep h ro l o g y - u ro l o g y - de v i c es - m a r ke t / t o c Disclaimer © 2023 IMARC Al l R ights Reserved Th is Pub l i ca t ion and a l l i t ’ s con ten ts un less o therw ise men t i oned a re copy r i gh ted in the name o f I n t e rna t i ona l Marke t Ana lys i s Research and Consu l t ing ( IMARC) . No pa r t o f t h i s pub l i ca t ion may be rep roduced , repackaged , red i s t r i bu ted o r res o ld i n who le o r i n any pa r t . The pub l i ca t ion may a l so no t be used i n any f o rm o r by and means g raph i c e lec t ron ic o r mechan ic a l , i nc lud ing pho tocopy ing , reco rd ing , t ap ing o r by i n fo rmat i on s to rage o r re t r ieva l , o r by any o the r f o rm, w i t hou t the exp ress c ons en t o f I n t e rna t iona l Marke t Ana lys i s Research and Consu l t i ng ( IMARC) . Disc la imer : Al l con ten ts and da ta o f t h i s pub l i c a t i on , i nc lud ing fo recas t s , da ta ana lys i s and op in ion have been based on in f o rmat ion and sources be l ieved to be accu ra te and re l iab le a t t he t ime o f pub l i sh ing . In t e rna t i ona l Ma rke t Ana l ys is Research and Consu l t ing makes no rep resen ta t ion o f war ran t y o f any k ind as to t he acc u racy o r comp le teness o f any I n fo rmat i on p rov ided . IMARC accep ts no l i ab i l i t y wha tsoever f o r any los s o r damage resu l t i ng f rom op in ion , e r ro rs o r i naccu rac ies i f any f ound th is pub l i ca t ion . IMARC, IMARC Group and G loba l Therapy I ns igh t Ser i es a re reg is t e red t rademarks o f I n te rna t iona l Marke t Ana lys i s Research and Consu l t ing . A l l o the r t rademarks used i n th i s pub l i ca t i on a re reg i s te red t rademarks o f t he i r r espec t i ve compan ies . Contact Us Visit us at : https://www.imarcgroup.com TELEPHONE: +1-631-791-1145 E-MAIL: [email protected]